-
All Resources
(choose a category)
-
All Resources
-
selected
Evidence
Evidence, advice, guidance and standards
-
Improvement
Improvement and implementation support
-
Scrutiny
Assurance, scrutiny, measurement and reporting
-
-
Healthcare Area
- Blood and immune system
- Cancer
- Cardiovascular system
- Caring for older people
- Dermatology
- Digestive system
- Ear, nose and throat
- Endocrine, nutritional and metabolic
- Eye
- Genitourinary system
- Health service organisation and delivery
- Infectious disease
- Injuries, accidents and wounds
- Learning disability
- Mental and behavioural disorders
- Mouth and dental
- Musculoskeletal system
- Nervous system
- Obstetrics and gynaecology
- Paediatrics
- Palliative care
- Patient experience
- Physical disability
- Public health
- Respiratory system
- Resource Type
- Programme
- Year
480 results found filtered by Evidence Remove Evidence Filter Clear Search
-
Wrapping dental Instruments: Advice Statement 002-10
- Published
- 18 November 2010
- Cycle of Improvement
- Evidence
-
Evidence based assessment report 2010-004
- Published
- 10 November 2010
- Cycle of Improvement
- Evidence
-
An audit of amniocentesis & chorionic villus sampling
- Published
- 09 November 2010
- Cycle of Improvement
- Evidence
-
ECMO for respiratory support in adults: evidence note 30
- Published
- 01 November 2010
- Cycle of Improvement
- Evidence
-
Appraisal Guidance No 201 Omalizumab for the treatment of severe persistent allergic asthma in children aged 6-11
- Published
- 27 October 2010
- Cycle of Improvement
- Evidence
-
Appraisal Guidance No 202 Ofatumumab for the treatment of refractory chronic lymphocytic leukaemia
- Published
- 27 October 2010
- Cycle of Improvement
- Evidence
-
Appraisal Guidance No 207 – Temsirolimus for the treatment of relapsed or refractory mantle cell lymphoma (terminated ap
- Published
- 27 October 2010
- Cycle of Improvement
- Evidence
-
Appraisal Guidance No. 204 Denosumab for the prevention of osteoporotic fractures
- Published
- 27 October 2010
- Cycle of Improvement
- Evidence
-
Appraisal Guidance no. 205 Eltrombopag for treatment of thrombocytopenic purpura
- Published
- 27 October 2010
- Cycle of Improvement
- Evidence
-
Appraisal Guidance No 206 – Bendamustine for the treatment of indolent (low grade) non-Hodgkin’s lymphoma that is refrac
- Published
- 27 October 2010
- Cycle of Improvement
- Evidence